DBT (ALDBT.PA) Stock Fundamental Analysis

EPA:ALDBT • FR001400LO86

0.0659 EUR
0 (-3.09%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Taking everything into account, ALDBT scores 2 out of 10 in our fundamental rating. ALDBT was compared to 69 industry peers in the Electrical Equipment industry. ALDBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALDBT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALDBT has reported negative net income.
  • ALDBT had a negative operating cash flow in the past year.
  • ALDBT had negative earnings in each of the past 5 years.
  • In the past 5 years ALDBT always reported negative operating cash flow.
ALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFALDBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -14.55%, ALDBT is doing worse than 82.61% of the companies in the same industry.
  • ALDBT's Return On Equity of -46.17% is on the low side compared to the rest of the industry. ALDBT is outperformed by 81.16% of its industry peers.
Industry RankSector Rank
ROA -14.55%
ROE -46.17%
ROIC N/A
ROA(3y)-23.56%
ROA(5y)-31%
ROE(3y)-52.67%
ROE(5y)-63.14%
ROIC(3y)N/A
ROIC(5y)N/A
ALDBT.PA Yearly ROA, ROE, ROICALDBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 31.98%, ALDBT is doing worse than 62.32% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALDBT has grown nicely.
  • The Profit Margin and Operating Margin are not available for ALDBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.62%
ALDBT.PA Yearly Profit, Operating, Gross MarginsALDBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ALDBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALDBT has more shares outstanding
  • Compared to 5 years ago, ALDBT has less shares outstanding
  • Compared to 1 year ago, ALDBT has a worse debt to assets ratio.
ALDBT.PA Yearly Shares OutstandingALDBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALDBT.PA Yearly Total Debt VS Total AssetsALDBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -0.79, we must say that ALDBT is in the distress zone and has some risk of bankruptcy.
  • ALDBT's Altman-Z score of -0.79 is on the low side compared to the rest of the industry. ALDBT is outperformed by 82.61% of its industry peers.
  • There is no outstanding debt for ALDBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.79
ROIC/WACCN/A
WACC4.01%
ALDBT.PA Yearly LT Debt VS Equity VS FCFALDBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that ALDBT may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.67, ALDBT is doing worse than 92.75% of the companies in the same industry.
  • ALDBT has a Quick Ratio of 0.67. This is a bad value and indicates that ALDBT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.41, ALDBT is not doing good in the industry: 94.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.41
ALDBT.PA Yearly Current Assets VS Current LiabilitesALDBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • ALDBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.59%, which is quite impressive.
  • Looking at the last year, ALDBT shows a very negative growth in Revenue. The Revenue has decreased by -18.47% in the last year.
  • ALDBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.98% yearly.
EPS 1Y (TTM)87.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.08%
Revenue 1Y (TTM)-18.47%
Revenue growth 3Y32.91%
Revenue growth 5Y1.98%
Sales Q2Q%-29.93%

3.2 Future

  • Based on estimates for the next years, ALDBT will show a very strong growth in Earnings Per Share. The EPS will grow by 24.42% on average per year.
  • Based on estimates for the next years, ALDBT will show a very negative growth in Revenue. The Revenue will decrease by -90.45% on average per year.
EPS Next Y28.13%
EPS Next 2Y20.08%
EPS Next 3Y24.42%
EPS Next 5YN/A
Revenue Next Year25.09%
Revenue Next 2Y25.88%
Revenue Next 3Y-90.45%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALDBT.PA Yearly Revenue VS EstimatesALDBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
ALDBT.PA Yearly EPS VS EstimatesALDBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2024 2025 2026 2027 -2K -4K -6K

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ALDBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALDBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALDBT.PA Price Earnings VS Forward Price EarningsALDBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALDBT.PA Per share dataALDBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

  • ALDBT's earnings are expected to grow with 24.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.08%
EPS Next 3Y24.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALDBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DBT

EPA:ALDBT (2/27/2026, 7:00:00 PM)

0.0659

0 (-3.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners0.08%
Ins Owner ChangeN/A
Market Cap330.82K
Revenue(TTM)8.53M
Net Income(TTM)-4.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.05
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-3.86
Fwd EYN/A
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS1.7
BVpS2
TBVpS1.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.55%
ROE -46.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.98%
FCFM N/A
ROA(3y)-23.56%
ROA(5y)-31%
ROE(3y)-52.67%
ROE(5y)-63.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.62%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 259.76%
Cap/Sales 48.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.41
Altman-Z -0.79
F-Score3
WACC4.01%
ROIC/WACCN/A
Cap/Depr(3y)433.24%
Cap/Depr(5y)302.25%
Cap/Sales(3y)51%
Cap/Sales(5y)37.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.08%
EPS Next Y28.13%
EPS Next 2Y20.08%
EPS Next 3Y24.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.47%
Revenue growth 3Y32.91%
Revenue growth 5Y1.98%
Sales Q2Q%-29.93%
Revenue Next Year25.09%
Revenue Next 2Y25.88%
Revenue Next 3Y-90.45%
Revenue Next 5YN/A
EBIT growth 1Y19.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.41%
EBIT Next 3Y26.01%
EBIT Next 5YN/A
FCF growth 1Y-16.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.36%
OCF growth 3YN/A
OCF growth 5YN/A

DBT / ALDBT.PA FAQ

Can you provide the ChartMill fundamental rating for DBT?

ChartMill assigns a fundamental rating of 2 / 10 to ALDBT.PA.


Can you provide the valuation status for DBT?

ChartMill assigns a valuation rating of 1 / 10 to DBT (ALDBT.PA). This can be considered as Overvalued.


What is the profitability of ALDBT stock?

DBT (ALDBT.PA) has a profitability rating of 1 / 10.


Is the dividend of DBT sustainable?

The dividend rating of DBT (ALDBT.PA) is 0 / 10 and the dividend payout ratio is 0%.